138 related articles for article (PubMed ID: 16771816)
1. FTY720/cyclosporine regimens in de novo renal transplantation: a 1-year dose-finding study.
Mulgaonkar S; Tedesco H; Oppenheimer F; Walker R; Kunzendorf U; Russ G; Knoflach A; Patel Y; Ferguson R;
Am J Transplant; 2006 Aug; 6(8):1848-57. PubMed ID: 16771816
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial of FTY720 versus MMF in de novo renal transplantation.
Tedesco-Silva H; Pescovitz MD; Cibrik D; Rees MA; Mulgaonkar S; Kahan BD; Gugliuzza KK; Rajagopalan PR; Esmeraldo Rde M; Lord H; Salvadori M; Slade JM;
Transplantation; 2006 Dec; 82(12):1689-97. PubMed ID: 17198261
[TBL] [Abstract][Full Text] [Related]
3. FTY720 versus MMF with cyclosporine in de novo renal transplantation: a 1-year, randomized controlled trial in Europe and Australasia.
Salvadori M; Budde K; Charpentier B; Klempnauer J; Nashan B; Pallardo LM; Eris J; Schena FP; Eisenberger U; Rostaing L; Hmissi A; Aradhye S;
Am J Transplant; 2006 Dec; 6(12):2912-21. PubMed ID: 17061999
[TBL] [Abstract][Full Text] [Related]
4. FTY720 versus mycophenolate mofetil in de novo renal transplantation: six-month results of a double-blind study.
Tedesco-Silva H; Szakaly P; Shoker A; Sommerer C; Yoshimura N; Schena FP; Cremer M; Hmissi A; Mayer H; Lang P;
Transplantation; 2007 Oct; 84(7):885-92. PubMed ID: 17984842
[TBL] [Abstract][Full Text] [Related]
5. FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.
Tedesco-Silva H; Mourad G; Kahan BD; Boira JG; Weimar W; Mulgaonkar S; Nashan B; Madsen S; Charpentier B; Pellet P; Vanrenterghem Y
Transplantation; 2005 Jun; 79(11):1553-60. PubMed ID: 15940045
[TBL] [Abstract][Full Text] [Related]
6. FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.
Tedesco-Silva H; Mourad G; Kahan BD; Boira JG; Weimar W; Mulgaonkar S; Nashan B; Madsen S; Charpentier B; Pellet P; Vanrenterghem Y
Transplantation; 2004 Jun; 77(12):1826-33. PubMed ID: 15223899
[TBL] [Abstract][Full Text] [Related]
7. Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models.
Nikolova Z; Hof A; Baumlin Y; Hof RP
Transpl Immunol; 2001 Feb; 8(4):267-77. PubMed ID: 11316070
[TBL] [Abstract][Full Text] [Related]
8. FTY720 combined with tacrolimus in de novo renal transplantation: 1-year, multicenter, open-label randomized study.
Hoitsma AJ; Woodle ES; Abramowicz D; Proot P; Vanrenterghem Y;
Nephrol Dial Transplant; 2011 Nov; 26(11):3802-5. PubMed ID: 21911597
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine.
Troncoso P; Stepkowski SM; Wang ME; Qu X; Chueh SC; Clark J; Kahan BD
Transplantation; 1999 Jan; 67(1):145-51. PubMed ID: 9921811
[TBL] [Abstract][Full Text] [Related]
10. Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or in combination with cyclosporine or RAD.
Schuurman HJ; Menninger K; Audet M; Kunkler A; Maurer C; Vedrine C; Bernhard M; Gaschen L; Brinkmann V; Quesniaux V
Transplantation; 2002 Oct; 74(7):951-60. PubMed ID: 12394836
[TBL] [Abstract][Full Text] [Related]
11. FTY720 immunomodulation: optimism for improved transplant regimens.
Ferguson R
Transplant Proc; 2004 Mar; 36(2 Suppl):549S-553S. PubMed ID: 15041404
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic/pharmacodynamic relationships of FTY720 in kidney transplant recipients.
Park SI; Felipe CR; Machado PG; Garcia R; Skerjanec A; Schmouder R; Tedesco-Silva H; Medina-Pestana JO
Braz J Med Biol Res; 2005 May; 38(5):683-94. PubMed ID: 15917949
[TBL] [Abstract][Full Text] [Related]
13. The novel immunosuppressant FTY720 induces peripheral lymphodepletion of both T- and B-cells in cynomolgus monkeys when given alone, with Cyclosporine Neoral or with RAD.
Quesniaux VF; Menninger K; Kunkler A; Vedrine C; Bernhard M; Hedinger R; Kraus G; Schuurman HJ
Transpl Immunol; 2000 Nov; 8(3):177-87. PubMed ID: 11147698
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study.
Kahan BD; Karlix JL; Ferguson RM; Leichtman AB; Mulgaonkar S; Gonwa TA; Skerjanec A; Schmouder RL; Chodoff L
Transplantation; 2003 Oct; 76(7):1079-84. PubMed ID: 14557756
[TBL] [Abstract][Full Text] [Related]
15. FTY720, a novel immunomodulator in de novo kidney transplant patients: pharmacokinetics and exposure-response relationship.
Skerjanec A; Tedesco H; Neumayer HH; Cole E; Budde K; Hsu CH; Schmouder R
J Clin Pharmacol; 2005 Nov; 45(11):1268-78. PubMed ID: 16239360
[TBL] [Abstract][Full Text] [Related]
16. Combined FTY720/cyclosporine treatment promotes graft survival and lowers the peripheral lymphocyte count in a murine cardiac allotransplantation model.
Nikolova Z; Hof A; Baumlin Y; Hof RP
Transplantation; 2001 Jul; 72(1):168-71. PubMed ID: 11468555
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus in combination with FTY720--an analysis of renal and blood parameters.
Gallo AP; Silva LB; Franco M; Burdmann EA; Bueno V
Int Immunopharmacol; 2006 Dec; 6(13-14):1919-24. PubMed ID: 17219691
[TBL] [Abstract][Full Text] [Related]
18. An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients.
Sommerer C; Suwelack B; Dragun D; Schenker P; Hauser IA; Witzke O; Hugo C; Kamar N; Merville P; Junge M; Thaiss F; Nashan B;
Kidney Int; 2019 Jul; 96(1):231-244. PubMed ID: 31027892
[TBL] [Abstract][Full Text] [Related]
19. The impact of FTY720 (fingolimod) on vasodilatory function and arterial elasticity in renal transplant patients.
Westhoff TH; Schmidt S; Glander P; Liefeld L; Martini S; Offermann G; Neumayer HH; Zidek W; van der Giet M; Budde K
Nephrol Dial Transplant; 2007 Aug; 22(8):2354-8. PubMed ID: 17526535
[TBL] [Abstract][Full Text] [Related]
20. First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients.
Budde K; Schmouder RL; Brunkhorst R; Nashan B; Lücker PW; Mayer T; Choudhury S; Skerjanec A; Kraus G; Neumayer HH
J Am Soc Nephrol; 2002 Apr; 13(4):1073-1083. PubMed ID: 11912269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
